The Center for Process Innovation (CPI) is collaborating with partners GSK and AstraZeneca to establish a bespoke, continuous wet granulation manufacturing facility for small-scale development of oral solid dosage pharmaceuticals.   The new facility, built as part of a project called PROSPECT CP, will include blending and feeding of raw materials, twin screw wet granulation, drying and ultimately tableting. The facility is designed to include integrated in-line process analytical technologies ...